Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Dr. Kelly Bruns from the Nebraska College of Technical Agriculture discusses how the college prepares students for careers in agriculture.
RFD NEWS Correspondent Frank McCaffrey was in Mission, Texas, where state and federal officials addressed growers and producers at a round table event hosted at a citrus grower’s facility. He shows us how welcome news was all around.
New Holland VP Ryan Schaefer shares insights into the brand’s legacy and innovations that support U.S. cattle producers.
Federal assistance has helped, but the most recent row-crop losses remain on producers’ balance sheets.
OOIDA’s Lewie Pugh discusses the EPA’s new Right to Repair guidance and other regulatory developments impacting the trucking and agriculture industries.
